Modo Michel
King's College London, Institute of Psychiatry, Centre for the Cellular Basis of Behaviour, SE5 9NU, London, UK.
Methods Mol Biol. 2011;771:717-32. doi: 10.1007/978-1-61779-219-9_35.
Cell tracking by magnetic resonance imaging (MRI) is an essential tool to understand the integration and migration of transplanted cells in vivo. At present, however, techniques to visualize cell transplants in patients are fairly limited and further development of cellular MRI is needed to advance the monitoring of grafted cells. The use of contrast agents to pre-label cells prior to transplantation is currently needed as transplanted cells integrate seamlessly into existing parenchyma and hence are indistinguishable from host cells. The development of appropriate contrast agents, as well as their in vitro incorporation into cells, is key to visualizing transplanted cells in vivo. We describe here procedures regarding how the in vitro incorporation of MR contrast agents can be tested, how they might affect cellular functions and how we can determine if sufficient contrast agent has been incorporated to allow detection. Before this technique can find its clinical application, in vitro and preclinical in vivo studies need to be conducted to determine the safety and specificity of this approach.
通过磁共振成像(MRI)进行细胞追踪是了解体内移植细胞整合与迁移的重要工具。然而目前,用于可视化患者体内细胞移植的技术相当有限,需要进一步发展细胞MRI以推进对移植细胞的监测。由于移植细胞会无缝整合到现有的实质组织中,因此与宿主细胞难以区分,目前需要使用造影剂在移植前对细胞进行预标记。开发合适的造影剂以及将其体外掺入细胞是在体内可视化移植细胞的关键。我们在此描述了有关如何测试MR造影剂的体外掺入、它们如何影响细胞功能以及如何确定是否已掺入足够的造影剂以实现检测的程序。在该技术找到临床应用之前,需要进行体外和临床前体内研究以确定该方法的安全性和特异性。